Home -> Law Blog Directory -> Patent Law Blogs -> Florida Intellectual Property Law Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Florida Intellectual Property Law BlogPatent Revocation: A Significant Risk?
By John Rizvi
I am often asked by inventors about the risks of having their patent revoked at a later date. The United States Patent and Trademark Office doesn't make it easy to get a patent. Florida patent attorneys like myself work through excruciating details to secure the approval of our clients' patent applications. The USPTO also puts a significant amount of time into prior art searching and research prior to granting a patent and is necessarily reluctant to take a patent away once it's been issued.
I read an article today about the USPTO's decision to tentatively nullify four patents held by Gilead Sciences, which cover a drug that treats AIDS patients (San Jose Mercury News, January 24, 2008). A consumer advocacy group up the coast from Florida (in New York) called the Public Patent Foundation is the third-party challenger in this case, claiming Gilead's patents are invalid, because they'd publicly disclosed the technology behind the drug.
This brings up something I consistently counsel Florida patent seekers (and patent seekers everywhere) against. It is vitally important not to publicly disclose your idea--and in fact not to disclose it except under absolute necessity--before filing for a patent. The USPTO can, and certainly will, reject a patent application for an idea already in the public eye.
Now, the chances are small that Gilead, having already secured their four patents, will have their patents revoked. (Even the Public Patent Foundation admits the unlikeliness of this.) And, Gilead, which earned $3.1 Billion in sales based on their patents, says they will "vigorously defend each and every claim." With that big a business riding on it, I'm sure they will.
Full post as published by Florida Intellectual Property Law Blog on January 24, 2008 (boomark / email).
Lipitor
Review of Studies Show No Significant Benefit in Women
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

Blakely, Booker & Supervised Release Revocation
Soccer League Treasurer Sanctioned
Patent Failure, Patent Reform Legislation
No Revocation For Suspended Lawyer
CA1: supervised release revocation doesnt get Booker or Blakely protection








